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Defensive behaviorTonic immobility (TI) is an innate defensive behavior that can be elicited by physical restriction and postural
inversion and is characterized by a profound and temporary state of akinesis. Our previous studies demon-
strated that the stimulation of serotonin receptors in the dorsal raphe nucleus (DRN) appears to be biphasic
during TI responses in guinea pigs (Cavia porcellus). Serotonin released by the DRN modulates behavioral re-
sponses and its release can occur through the action of different neurotransmitter systems, including the
opioidergic and GABAergic systems. This study examines the role of opioidergic, GABAergic and serotonergic
signaling in the DRN in TI defensive behavioral responses in guinea pigs. Microinjection of morphine (1.1 nmol)
or bicuculline (0.5 nmol) into the DRN increased the duration of TI. The effect ofmorphine (1.1 nmol)was antag-
onized by pretreatmentwith naloxone (0.7 nmol), suggesting that the activation of μ opioid receptors in theDRN
facilitates the TI response. By contrast, microinjection of muscimol (0.5 nmol) into the DRN decreased the
duration of TI. However, a dose of muscimol (0.26 nmol) that alone did not affect TI, was sufﬁcient to inhibit
the effect of morphine (1.1 nmol) on TI, indicating that GABAergic and enkephalinergic neurons interact in
the DRN. Microinjection of alpha-methyl-5-HT (1.6 nmol), a 5-HT2 agonist, into the DRN also increased TI.
This effect was inhibited by the prior administration of naloxone (0.7 nmol). Microinjection of 8-OH-DPAT
(1.3 nmol) also blocked the increase of TI promoted by morphine (1.1 nmol). Our results indicate that the
opioidergic, GABAergic and serotonergic systems in the DRN are important for modulation of defensive
behavioral responses of TI. Therefore, we suggest that opioid inhibition of GABAergic neurons results in
disinhibition of serotonergic neurons and this is the mechanism by which opioids could enhance TI.
Conversely, a decrease in TI could occur through the activation of GABAergic interneurons.
© 2012 Elsevier Inc. Open access under the Elsevier OA license.1. Introduction
Tonic immobility (TI), also known as “animal hypnosis” or “death
feigning”, is an innate defensive behavioral response that is character-
ized by profound physical inactivity and a relative lack of responsiveness
to environmental stimuli. Tonic immobility may be experimentally
induced by postural inversion in conjunction with slightly restricting
the animal's movement. The duration of TI can vary across species
and depends on environmental conditions [1]. The end of a TI epi-
sode is characterized by an abrupt restoration of the animal's typical
posture [2]. This behavioral response is the last line of defense used
by prey to survive during a predatory attack [3]. Conﬁrming the efﬁ-
cacy of this tactic, Sargeant and Eberhardt [4] showed that 58% of
wild ducks that exhibited TI when attacked by foxes (Vulpes fulva)
survived the initial attack. Another indication of the adaptive valueSchool of Medicine of Ribeirão
o, SP, Brazil. Tel.: +55 16 602
de-Oliveira).
evier OA license.of TI was demonstrated by Thompson and colleagues [3], who
demonstrated that TI reduced the time that cats attacked quails.
Studies from our laboratory have investigated the involvement of
neural structures in the TI defensive response. We have shown the
involvement of different structures, including the parabrachial area,
themedial hypothalamus, periaqueductal graymatter (PAG), the amyg-
dala, the nucleus raphe magnus (NRM), the anterior cingulate cortex,
the dorsal hippocampal formation (DHP, unpublished results) and the
dorsal raphe nucleus (DRN) [5–13].
Recently published data show that the activation of different sero-
tonin (5-HT) receptors in the DRN may modulate distinct aspects of
the TI defensive response. Microinjection of the 5-HT1A agonist 8-
OH-DPAT into the DRN promotes a reduction in TI duration, while
5-HT2 receptor stimulation by alpha-methyl-5-HT increases the dura-
tion of TI [13]. The DRN is located in the ventromedial PAG [14,15],
and is one of major sources of serotonergic afferents in the forebrain
and midbrain [16]. The neurotransmitter 5-HT has an important role
in modulating cognitive function and affective and neuroendocrine
responses [17]. The heterogeneous nature of the DRN is reﬂected in
the variety of behaviors inﬂuenced by the 5-HT that is released from
the DRN. These behaviors include sleep, sexual behavior, feeding,
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Defensive behaviors can also bemodulated by 5-HT, based on its pat-
tern of release to different brain structures [18], and TI seems to be
highly inﬂuenced by the level of 5-HT in the brain [19]. In the DRN,
serotonergic neurons are the most abundant type of neuron [14,15].
However, neurons that release other neurotransmitters and neuro-
modulators are also present, including enkephalin and gamma-
aminobutyric acid (GABA) releasing neurons [15,20–22].
It is known that opioid peptides can alter extracellular levels of
5-HT. According to Grauer and colleagues [23] and Tao and Auerbach
[21], morphine microinjection into the DRN increased the extracellular
concentration of 5-HT in neural areas that are innervated by this nucleus.
Some studies have reported the presence of opioid receptors in the
DRN [24–26], and μ-opioids reduce GABA-mediated postsynaptic
currents in 5-HT neurons [22]. GABA is the main inhibitory neuro-
transmitter in the brain and can be found in 40% of vertebrate neu-
rons [27]. Tao and colleagues [28] demonstrated that GABAA and
GABAB receptors are present in the DRN and could be involved in
reducing 5-HT release. GABAergic afferents make inhibitory synap-
ses directly on 5-HT neurons in the DRN [29,30].
Tao and Auerbach [31] showed, using microdialysis, that opioid
receptor activation is responsible for 5-HT release through the inhibi-
tion of GABAergic afferents in the DRN. Another study shows that
approximately 80% of DRN GABAergic cells are μ-opioid receptor im-
munoreactive [25]. In accordancewith these results, GABAergic stimu-
lation in the DRN of rats attenuated the increase in 5-HT release
produced by morphine [32]. Neurochemical methods utilized by Tao
and Auerbach [33] also showed that morphine administration into
the DRN in anesthetized rats caused an increase in 5-HT metabolism
and release [32,34] and a concomitant decrease in GABA release in
the DRN [35]. Therefore, GABA inhibition by morphine could facili-
tate serotonergic neurotransmission.
Opioid, GABA and serotonin circuits in the DRN that regulate 5-HT
release in other brain areas [15–17,32,34,36] could modulate defen-
sive responses, including TI. Thus, the purpose of this study was to in-
vestigate the role of opioidergic, GABAergic and serotonergic neurons
and their interactions with each other in the DRN in the modulation
of tonic immobility behavioral responses in guinea pigs.
2. Materials and methods
2.1. Animals
In this study, we used 82 male guinea pigs (Cavia porcellus), weigh-
ing 430–480 g, from the animal care facility of Ribeirão Preto Medical
School (FMRP). Throughout the experimental period, the animals were
housed in plexiglass cages (56×37×39 cm, ﬁve animals per cage)
lined with wood shavings, with controlled illumination (12/12 h) and
temperature (24±1 °C). The guinea pigs had free access to food (guinea
pig speciﬁc food and fresh grass) and water ad libitum. All experiments
were performed in compliance with the recommendations of the
College of Animal Experimentation (COBEA) and with the approval
(Proc.no.089/2007) of the Ethical Committee for Animal Experimen-
tation of the School of Medicine of Ribeirão Preto of the University of
São Paulo. All efforts were made to minimize animal suffering.
2.2. Drugs
The substances morphine sulfate (opioid agonist), naloxone hydro-
chloride (opioid antagonist), muscimol (GABAA receptor agonist), bicu-
culline methiodide (GABAA receptor antagonist), 8-OH-DPAT (5-HT1A
agonist) and alpha-methyl-5-hydroxytriptamine (5-HT2 agonist) were
diluted in saline (0.9% NaCl) on the day of the experiment, according
to previous studies [37–40]. All substances were obtained from Sigma,
St. Louis-USA.2.3. Surgical procedures
Animals were anesthetized by intramuscular injection of both
ketamine (40 mg/kg) and xylazine (5 mg/kg). Following anesthesia,
we performed the dorsal head trichotomy in a stereotaxic apparatus
(David-Kopf Instruments, USA) for small animals. A guide cannula
was implanted in the DRN, which was located using the Rössner atlas
[41] for guinea pigs: AP: +10.8 mm caudal to bregma, L: +3.0 mm lat-
eral to themidline and P:−8.0 mm from the skull, with a 30° angle. The
cannula was placed 1.0 mm dorsal to the DRN. The guide cannula was
prepared from hypodermic needles segments that had a 0.6 mm outer
diameter and were 14 mm long.
2.4. Microinjection procedure
We used a Hamilton microsyringe (10 μl) that was connected
through a segment of polyethylene (PE 10) to a thin dental needle
(Mizzi, USA) that was 15 mm long and had a 0.3 mm inner diameter.
The 15 mm needle injection length extended 1 mm beyond the can-
nula guide and reached the DRN. The microinjection was performed
in 60 s, and the needle was left in place for an additional 60 s to pre-
vent reﬂux of the injected solutions. All solutions were microinjected
in a total volume of 0.2 μl.
2.5. Tonic immobility recordings
The tonic immobility procedure was performed during the same
period of the day, (from 13:00 to 18:00 h) to reduce variability in
the results. The animals were maintained for 20 min in the experi-
mental room prior to the start of the experiment to habituate the
animal and reduce environmental stress. The animals were placed
in V-shaped boxes (25 cm long×15 cm high) that were lined with
nylon foam. TI inductionwas performed by quickly posturally inverting
the animals and then manually restraining them until the animal did
not resist this procedure. At this moment, the experimenter slowly
withdrew his hands and a chronometer was activated to measure (in
seconds) the duration of the TI episode. The episode was determined
to be over when the guinea pig returned to a habitual posture on four
legs. Each naive animal was subjected to ﬁve consecutive TI inductions,
with a randomized interval of between 40 and 90 s between each epi-
sode (control condition). Animals that had an average TI episode length
of greater than 45 s under control conditions had a guide cannula
implanted in the DRN. Five to seven days after stereotaxic surgery, the
animals were submitted to a TI session in the absence of drug injection
to control for postoperative effects, (sham condition). The following
day, the animals were microinjected with drugs and, after each treat-
ment, ﬁve TI episodeswas againmeasured. A fourth day of experiments
was performed when we microinjected an antagonist ten minutes
before the agonist (as was the case in experiments 4, 9 and 10) prior
to inducing TI. The behavioral observations started 1 min after the
drugs had been microinjected.
2.6. Experimental procedures
To evaluate the effect of opioidergic stimulation in the DRN, animals
were divided into four experimental groups: experiment 1 (n=7), the
animals received a microinjection of saline (NaCl 0.9%) as a vehicle
control; experiment 2 (n=10), the animals were microinjected with
morphine (1.1 nmol); experiment 3, the guinea pigswere administered
with naloxone (0.7 nmol) (n=6); and experiment 4 (n=11), the
animals received a microinjection of naloxone (0.7 nmol) followed
ten minutes later by a microinjection of morphine (1.1 nmol).
Three other groups of animals were tested for the role of GABA in
guinea pig DRN stimulation. In experiments 5 (n=8) and 6 (n=11),
the animals were microinjected with 0.26 and 0.5 nmol of muscimol,
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with bicuculline (0.5 nmol) in the DRN.
Finally, in the last three experiments, we investigated whether the
opioidergic, serotonergic and GABAergic systems interact in the DRN.
In experiment 8 (n=6), the guinea pigs were pretreated with alpha-
methyl-5-HT (1.6 nmol). In experiment 9 (n=7), the animals were
microinjected with naloxone (0.7 nmol) prior to the treatment of the
DRN with alpha-methyl-5-HT (1.6 nmol; ten minutes). In experiment
10 (n=7), the animals were microinjected with muscimol (0.26 nmol)
followed by morphine (1.1 nmol, 10 min) in the DRN; in experiment
11 (n=8), the animals received a microinjection of 8-OH-DPAT
(1.3 nmol) followed ten minutes later by a microinjection of mor-
phine (1.1 nmol) in the DRN.2.7. Histological analyses
After all procedures, the animals were deeply anesthetized with
sodium pentobarbital and perfused intracardially with saline followed
by 10% formalin for tissue ﬁxation. The guinea pig brainswere removed
and ﬁxed in 10% formalin for 3 days followed by incubation in a solution
of sucrose for three additional days. Afterﬁxation, a histological analysis
was performed in which we used the Nissl coloration technique for
analysis of the site of microinjection. Only guinea pigs that had
their microinjection site located within the DRN according to the
Rössner Atlas [41] for guinea pigs were included in the data analysis.2.8. Statistical analyses
The TI results were expressed as the mean±standard error of the
mean (SEM) for the ﬁve TI episodes. Analysis of variance (ANOVA) for
repeated measures was used for statistical analyses, and the statistical
differences between groups were determined by a Duncan post-test,
with the level of signiﬁcance set at pb0.05.Fig. 1. Duration of tonic immobility (TI) episodes. Data are presented as the mean±S.E.M. (
(SAL, 0.2 μl; n=7) microinjection into the dorsal raphe nucleus (DRN); (B) TI duration aft
DRN. *pb0.05 when compared to the control and sham conditions; (C) TI duration after
DRN; (D) TI duration after microinjection of naloxone (0.7 nmol) followed 10 min later by th
to the control, sham and naloxone+morphine conditions.3. Results
3.1. Effect of opioidergic agonist and antagonist microinjection into the
DRN
Microinjection of morphine (MS, 1.1 nmol) increased the duration
of TI (Fig. 1B). One-way ANOVA followed by Duncan post-test showed
that the increase in the duration of TI after morphine microinjection
was statistically signiﬁcant (F(2,18)=11.52, p=0.0006). The increase
in the duration of TI was blocked by prior microinjection of naloxone
(NAL, 0.7 nmol, Fig. 1D). An ANOVA for repeated measures indicates a
signiﬁcant difference between treatments (F(3,30)=6.07, p=0.0023),
and a Duncan post-test showed that treatment with morphine was
different from all other treatments (control, sham and naloxone and
morphine). In contrast, the control, sham and naloxone andmorphine
conditions did not differ from one another (p>0.05). In addition, the
microinjection of saline and naloxone (0.7 nmol, Fig. 1C) in the DRN
of different groups of guinea pigs did not alter the mean duration of
TI (p>0.05). Fig. 2 shows a schematic representation of the saline
and opioidergic agonist and antagonist microinjection sites in the
guinea pig DRN.3.2. Effect of GABAergic agonist and antagonist microinjection into the
DRN
Microinjection of 0.5 nmol of muscimol (Musc) decreased the
duration of TI in guinea pigs (Fig. 3Ab). An ANOVA for repeated
measures followed by Duncan post-test indicated a statistically sig-
niﬁcant difference (F(2,20)=4.54, P=0.0236) between the group that
received muscimol and the control and sham groups. By contrast, bicu-
culline (BIC, 0.5 nmol) microinjection in another group of animals in-
creased the duration of TI episodes (Fig. 3B). An ANOVA for repeated
measures followed by a Duncan post-test (F(2,16)=17.10, p=0.0014)
indicated a difference between the control and sham groups whenA) TI duration under control conditions (CONT), after surgery (SHAM) and after saline
er microinjection of the opioidergic agonist morphine (MS, 1.1 nmol; n=10) into the
microinjection of the opioidergic antagonist naloxone (NAL, 0.7 nmol; n=6) in the
e microinjection of morphine (NAL+MS, 1.1 nmol; n=11), #pb0.05 when compared
Fig. 2. Schematic drawings of the frontal sections obtained at representative levels of
the guinea pig DRN, indicating the site of microinjection (ﬁlled circles, •) of saline (I),
morphine (1.1 nmol, II), naloxone (0.7 nmol, III) and naloxone (0.7 nmol) followed
by morphine (1.1 nmol, IV). Abbreviations: PAG, periaqueductal gray matter; A, brain
aqueduct.
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tion of muscimol (0.26 nmol, Fig. 3Aa) did not alter (p>0.05) the dura-
tion of TI episodes. Fig. 3C I and II shows a schematic representation of
the GABAergic agonist and antagonist microinjection sites in the guinea
pig DRN.
3.3. Effect of opioidergic, GABAergic and serotonergic system interactions
in the DRN on modulating the TI response
Microinjection of alpha-methyl-5-HT (Mth, 1.6 nmol) increased the
duration of TI in guinea pigs (Fig. 4A). A Duncan post-test indicated a
statistically signiﬁcant difference between the group that received
alpha-methyl-5-HT when compared with the control and sham groupsFig. 3. Duration of tonic immobility (TI) episodes. Data are presented as the mean±S.E.M. (
injection with the GABAA agonist muscimol [Aa (Musc, 0.26 nmol; n=8), Ab (Musc, 0.5 nm
line (BIC, 0.5 nmol; n=9) into the DRN, *pb0.05 compared to the control and sham conditio
levels of the guinea pig DRN indicating the site of microinjection (ﬁlled circles, •) of muscim
ations: PAG, periaqueductal gray matter; A, brain aqueduct.(one-way ANOVA; F(2,10)=12.07, p=0.0022). However, prior mi-
croinjection (10 min before) of naloxone (NAL, 0.7 nmol) blocked
the increase of TI that was promoted by alpha-methyl-5-HT (Fig. 4B).
The group microinjected with 1.6 nmol of alpha-methyl-5-HT was
signiﬁcantly different (ANOVA, F(3,18)=6.87, p=0.0028) from the
control, sham and naloxone and alpha-methyl-5-HT groups accord-
ing to a Duncan post-test. Fig. 4C shows a schematic representation
of 5-HT-opioid interactions sites in the guinea pig DRN.
Microinjection of muscimol (Musc; 0.26 nmol) 10 min before mor-
phine (MS; 1.1 nmol) blocked the increase in TI produced by the mi-
croinjection of morphine alone in the DRN (Fig. 5A). An ANOVA for
repeatedmeasures followed by Duncan post-test indicated a statisti-
cally signiﬁcant difference (F(3,18)=15.36; p=0.0001) between the
group that received morphine and the control, sham and muscimol
and morphine groups. Prior microinjection (10 min before) of 8-
OH-DPAT (DPAT, 1.3 nmol) also blocked the increase of TI that was
promoted by morphine (MS; 1.1 nmol). Fig. 5B shows that the group
microinjected with 1.1 nmol of morphine was signiﬁcantly different
(ANOVA, F(21,3)=6.984, p=0.002) from the control, sham and 8-OH-
DPAT+morphine groups according to a Duncan post-test.
Fig. 5C shows a schematic representation of opioid-GABA-5-HT
interactions sites in the guinea pig DRN.
4. Discussion
The results of this study indicate that the opioidergic, GABAergic
and serotonergic systems in the DRN are important for modulating
the TI behavioral response. Morphine (1.1 nmol; opioidergic agonist)
microinjection increased the duration of TI. This response was blocked
by pretreatment with naloxone (0.7 nmol; opioidergic antagonist) at
the same site. These data may indicate that the activation of DRN
μ-opioid receptors facilitates the TI behavioral response.
Other studies have shown that systemic administration of mor-
phine increased the duration of TI episodes in guinea pigs [42], rats
[43], chickens [44] and rabbits [45]. Our previous work has also dem-
onstrated that central microinjection of morphine in both ventrolat-
eral PAG and NRM [37,40] promoted an increase in the duration of
TI in guinea pigs. These responses were blocked by the prior admin-
istration of naloxone at the same site. This indicates that in theseA) TI duration under control conditions (CONT), after surgery (SHAM) and after micro-
ol; n=11)] in the DRN; (B) TI duration after injection of the GABAA antagonist bicucul-
ns; (C) Schematic drawings of the frontal sections that were obtained at representative
ol (0.26 nmol, CI), muscimol (0.5 nmol, CII) and bicuculline (0.5 nmol, CIII). Abbrevi-
Fig. 4. Duration of tonic immobility (TI) episodes. Data are presented as the mean±S.E.M. (A) TI duration under control conditions (CONT), after surgery (SHAM) and after injection
of the 5-HT2 agonist [α-methyl-5-HT (Mth, 1.6 nmol; n=6)] in the DRN, *pb0.05 compared to control and sham conditions; (B) TI duration after naloxone (0.7 nmol) followed
10 min later by α-methyl-5-HT (NAL+Mth, 1.6 nmol; n=7). #pb0.05 compared to the control, sham and naloxone+α-methyl-5-HT conditions. (C) Schematic drawings of
the frontal sections that were obtained at representative levels of the guinea pig DRN indicating the site of microinjection (ﬁlled circles, •) of α-methyl-5-HT (1.6 nmol, CI), nalox-
one (0.7 nmol) followed by α-methyl-5-HT (1.6 nmol, CII). Abbreviations: PAG, periaqueductal gray matter; A, brain aqueduct.
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activation of the μ-opioid receptor subtype. These data support the
results of this study that morphine increases the duration of TI.
Nevertheless, a different result was observed after morphine micro-
injection in the central nucleus of the amygdala. Microinjection of
morphine in this structure decreased the duration of TI [46]. In ac-
cordance with these results, we can assume that the opioidergic
system is important in modulating the duration of TI defensive be-
haviors, and thus, the central nucleus of the amygdala may have
an inhibitory role in TI.
Regarding the role of the GABAergic system in modulating TI
behavioral responses in the DRN of guinea pigs, we found that intra-
DRN microinjection of muscimol (0.5 nmol; GABAA agonist) decreased
the duration of TI episodes. In contrast, bicuculline microinjection
(0.5 nmol; GABAA antagonist) in the same nucleus promoted the
opposite effect, (i.e., increasing TI duration). These results indicate
that GABA plays a potentially inhibitory role in the DRN in mediat-
ing TI defensive behavior.
Some studies have pointed to the involvement of GABAergic cir-
cuits in the brainstem in modulating defensive behavioral responsesFig. 5. Duration of tonic immobility (TI) episodes. Data are presented as the mean±S.E.M. (A
of the muscimol (0.26 nmol) followed 10 min later by morphine (Musc+MS, 1.1 nmol; n
(DPAT+MS, 1.1 nmol; n=8). (C) Schematic drawings of the frontal sections that were obta
(ﬁlled circles, •) of muscimol (0.26 nmol) followed by morphine (1.1 nmol, CI) and 8-OH-DP
sham conditions; Abbreviations: PAG, periaqueductal gray matter; A, brain aqueduct.[37,47,48]. Bicuculline microinjection in ventrolateral PAG, NRM or
the central nucleus of the amygdala increased the duration of TI epi-
sodes, whereas muscimol injection in these same neural regions de-
creased this response [37,40,46]. These data corroborate the results
of the current study because microinjection of muscimol into the
DRN caused a reduction in the average duration of the TI response,
while bicuculline increased this response.
The effect of GABAergic stimulation in the DRN was also veriﬁed
by Sena and colleagues [44], as they observed an increase in the
escape response of rats in a T-maze test after muscimol adminis-
tration into the DRN. Escape and TI are antagonistic responses be-
cause they involve different types of motor responses. In the presence
of TI, the animal remains in an unusual and ungainly posture, does not
move and is relatively unresponsive to external stimuli. In contrast,
during the escape response, the animal exhibits intense motor activ-
ity. Thus, we suggest that the decrease in the duration of TI following
GABAergic agonist (muscimol) microinjection in the DRN that we
observe is in agreement with the data found in the literature.
Recently published data [13] show that microinjection of alpha-
methyl-5-HT (5-HT2 agonist) in the DRN increased the duration of) TI duration under control conditions (CONT), after surgery (SHAM) and after injection
=7), (B) TI duration after 8-OH-DPAT (1.3 nmol) followed 10 min later by morphine
ined at representative levels of the guinea pig DRN indicating the site of microinjection
AT (1.3 nmol) followed by morphine (1.1 nmol, CII). *pb0.05 compared to control and
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ketanserin (5-HT2 antagonist). In the current study, we demonstrate
that an increase in TI produced by alpha-methyl-5-HT in the DRN
was also blocked by prior microinjection of naloxone. Based on these
ﬁndings, we can assume that stimulation of 5-HT2 excitatory recep-
tors possibly activates opioidergic interneurons present in the DRN.
A post-synaptic inhibition exerted by naloxone on μ receptors would
block the binding of enkephalin to receptors on GABAergic neurons,
thus preventing the disinhibition of serotonergic neurons to enhance
TI (see Fig. 6). Supporting this hypothesis, we observed that both
morphine and alpha-methyl-5-HT microinjection increased the du-
ration of the TI response. Our results suggest an interaction between
opioidergic and serotonergic systems in the DRN in modulating the
TI behavioral response in guinea pigs.
To verify the interaction between opioidergic and GABAergic sys-
tems in the DRN, we observed that the increase in the duration of TI
episodes after morphine microinjection in the DRN was blocked by
the prior administration of a dose of muscimol that had no effect on
its own. The action of opioids in the central nervous system is pre-
dominantly inhibitory, and the effect observed after morphine ad-
ministration may be due to an inhibition of tonic GABAergic activity
in the DRN, which possibly releases effector neurons in the DRN. Cor-
roborating this hypothesis, bicuculline administered in the DRN also
increased the duration of TI. The previous administration of 8-OH-
DPAT into the DRN of guinea pigs blocked the observed enhanced TI
duration after the microinjection of morphine alone. This result rein-
forces our hypothesis that opioids could increase the release of 5-HT
in the DRN. The activation of 5-HT1A receptors in the DRN of guinea
pigs could mediate a hyperpolarization of 5-HT neurons [49]. This
receptor is present on the cell soma and dendrites of 5-HT neurons
and their activation by 8-OH-DPAT inhibits the release of 5-HT [50].
Thus, the microinjection of 8-OH-DPAT before the morphine prevented
the disinhibition of 5-HT neurons in the DRN through the opioid activa-
tion. Thus, it is probable that the increased duration of the TI after the
morphine microinjection in the DRN of guinea pigs can occur due to
the release of serotonergic neurons as a result of the inhibition of
GABAergic interneurons (Fig. 6).
Tao and Auerbach [31,51] showed that opioids could indirectly in-
ﬂuence serotonergic neurons of the raphe nucleus by inhibiting
GABAergic afferents. Jolas and Aghajanian [22] further showed that
μ-opioids reduce GABA-mediated postsynaptic currents in 5-HT neu-
rons. Consistent with this hypothesis, Tao and Auerbach [33] found
that muscimol infusion in the DRN produced a decrease in the 5-HTFig. 6. Schematic diagram of the hypothesized interactions within the DRN for the opioid
α-methyl-5-HT microinjection might inhibit GABAergic neurons, disinhibiting DRN serotoner
inhibits the GABAergic neurons resulting in a disinhibition of output neurons in the DRN an
of GABA by inhibiting DRN output neurons and decreasing TI.Y, inhibitory transmission; , exci
5-HT2A receptor.release produced by morphine, thus inhibiting neural activity of the
DRN [52,53]. Tao and Auerbach [54] in another study observed that
the excitatory efferent pathways from the DRN are inhibited by toni-
cally active GABAergic afferents [55,56]. GABAergic neurons in the
DRN [29,30] are part of a feedback loop that inhibits serotonergic
neurons in the DRN [57]. Thus, according to Levine and Jacobs [58],
Nitz and Siegel [59] and Gervasoni et al. [60], GABA may be involved
in decreased serotonergic discharge during sleep.
The tonically active inhibitory circuit that modulates TI defensive
behavior is biologically important because the presence of this cir-
cuit would prevent the TI response from occurring at inappropriate
times. This is important because this response is characterized by a
profound inhibition of motor activity. Thus, only in very speciﬁc be-
havioral situations, such as during a prey/predator confrontation,
does the prey generate a TI response. In this case, there probably
would be a release of opioid peptides in the DRNwhichwould inhibit
tonic GABAergic activity, providing the necessary condition for the
maintenance of the TI defensive behavioral response.
Some studies from our laboratory have demonstrated a similar
circuit involving opioidergic and GABAergic neurons in other brain
regions in modulating the TI behavioral response. We have highlighted
the role of the ventrolateral PAG [37], and the NRM [40]. In the current
study, we assumed that the circuit involving opioids, GABA and seroto-
nin on the DRN could be responsible for balanced 5-HT release in the
projection areas of the DRN, which would be implicated in the modula-
tion of defensive responses, such as the TI response.
The PAG receive serotonergic afferents from the DRN [61], and
this region is also involved in TI modulation [8]. Thus, a possible in-
terpretation of our results could be a connection between the DRN
and the periaqueductal gray matter, resulting in the release of sero-
tonin in this structure and consequently the modulation of the dura-
tion of the TI response. However, we can not exclude the possibility
of other 5-HT interactions in modulating this response. In other
words, we can presume that the TI increase observed after morphine,
bicuculline and alpha-methyl-5-HT microinjection in the DRN could
occur by the activation of ascending 5-HT raphe neurons that project
to other brain regions that are involved in the modulation of defen-
sive responses. However, further studies are necessary to test this
hypothesis.
In summary, our results demonstrate that opioid receptor activa-
tion by morphine microinjection into the DRN facilitates TI defensive
behavioral responses in guinea pigs. In contrast, GABAergic neuro-
transmission acts to inhibit this response, as evidenced by a reductionergic, GABAergic, serotonergic systems involved in TI modulation. Local morphine or
gic output neurons that may act to increase TI duration. Local injection of bicuculline also
d thus also increasing TI duration. Muscimol may facilitate the tonic inhibitory action
tatory transmission. Abbreviations: GABA, GABAergic neuron; OP, opioidergic neuron; 2A,
115M.D. Ferreira, L. Menescal-de-Oliveira / Physiology & Behavior 106 (2012) 109–116in TI following muscimol administration in the DRN. Moreover, opioid
action probably occurs through the inhibition of tonically active
GABAergic interneurons because an ineffective dose of muscimol
blocked the effect of morphine. In addition, alpha-methyl-5-HT also
increased the duration of the TI response, an effect that was blocked
by prior microinjection of naloxone. This observation suggests a con-
nection between 5-HT2 receptors and opioidergic neurons in the DRN.
Within this context, we suggest a possible interaction between opioi-
dergic, GABAergic and serotonergic systems in the DRN that com-
poses a circuit that acts to balance the release of serotonin from the
DRN, thereby modulating TI behavioral responses.Acknowledgments
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